ConductScience.org, home

Paper39242587

Progress on the research and development of plague vaccines with a call to action.

Williamson ED and 5 others. NPJ Vaccines, 2024. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Progress on the research and development of plague vaccines with a call to action. Papers, record 39242587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39242587

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progress on the research and development of plague vaccines with a call to action.
PubMed
Journal
NPJ Vaccines
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
2.41, provisional
iCite
Revised in PubMed
2025-07-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Williamson EDE Dianehttps://orcid.org/0000-0002-0322-5972
2Kilgore PBPaul B
3Hendrix EKEmily K
4Neil BHBlake Hhttps://orcid.org/0009-0002-8091-0604
5Sha JJian
6Chopra AKAshok K

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI153524NIAID NIH HHSUnited StatesR01AI153524PubMedNIH RePORTER
T32 AI060549NIAID NIH HHSUnited StatesT32AI060549PubMedNIH RePORTER
T32 AI141349NIAID NIH HHSUnited StatesT32AI141349PubMed and NIHNIH RePORTER
T32AI179595NIHNIH RePORTER

Download CSV of grants

References129

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138605961Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice.Front Immunol2024https://conductscience.org/library/papers/38605961PubMed
29682370Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine.Vaccine1998https://conductscience.org/library/papers/9682370PubMed
331964555Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine.Vaccine2020https://conductscience.org/library/papers/31964555PubMed
48418045Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.Infect Immun1993https://conductscience.org/library/papers/8418045PubMed
517005799Resistance of Yersinia pestis to antimicrobial agents.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/17005799PubMed
635715352Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.Vaccine2022https://conductscience.org/library/papers/35715352PubMed
737954941The efficacy, safety, and immunogenicity of plague vaccines: A systematic literature review.Curr Res Immunol2023https://conductscience.org/library/papers/37954941PubMed
814651623Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica.Mol Microbiol2004https://conductscience.org/library/papers/14651623PubMed
920180652Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.Hum Gene Ther2010https://conductscience.org/library/papers/20180652PubMed
1011313139The failure of different strains of Yersinia pestis to produce lipopolysaccharide O-antigen under different growth conditions is due to mutations in the O-antigen gene cluster.FEMS Microbiol Lett2001https://conductscience.org/library/papers/11313139PubMed
1137289480Functional assays to screen and select monoclonal antibodies that target Yersinia pestis.Hum Vaccin Immunother2023https://conductscience.org/library/papers/37289480PubMed
1213808585The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague.J Immunol1959https://conductscience.org/library/papers/13808585PubMed
1338029221A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague.Front Microbiol2023https://conductscience.org/library/papers/38029221PubMed
1419490834Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integration.Microb Pathog2009https://conductscience.org/library/papers/19490834PubMed
1519200825A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.Vaccine2009https://conductscience.org/library/papers/19200825PubMed
1637029123Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37029123PubMed
1721763383Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.Vaccine2011https://conductscience.org/library/papers/21763383PubMed
1830985006Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization.Clin Exp Immunol2019https://conductscience.org/library/papers/30985006PubMed
1931199832Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015.PLoS One2019https://conductscience.org/library/papers/31199832PubMed
2030504873Comparing phenotypic variation between inbred and outbred mice.Nat Methods2018https://conductscience.org/library/papers/30504873PubMed

See all 129 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42892921Combination of live-attenuated and adenovirus-based vaccines provides immediate and durable protection against Yersinia pestis in mice.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42892921PubMed
42485432Live attenuated vaccines alone or in combination with an adenovirus-based vaccine protect mice lacking IFN-γ against pneumonic plague.Sci Transl Med2026https://conductscience.org/library/papers/42485432PubMed
42104293The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda.BMC Public Health2026https://conductscience.org/library/papers/42104293PubMed
41594581Virulence Reduction in Yersinia pestis by Combining Delayed Attenuation with Plasmid Curing.Biomolecules2025https://conductscience.org/library/papers/41594581PubMed
41530150Intranasal unadjuvanted LcrV boosts parental Yersinia OMV primed lung immunity against pneumonic plague in mice.Nat Commun2026https://conductscience.org/library/papers/41530150PubMed
41153833Plagued by the Past, Pressed by the Present: A One Health Perspective on Yersinia pestis.Biomedicines2025https://conductscience.org/library/papers/41153833PubMed
41071737Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network.Clin Infect Dis2025https://conductscience.org/library/papers/41071737PubMed
40972648Lipid A mimetic BECC438 potentiates durable and balanced antibody responses in an ovalbumin murine model of vaccination.Immunohorizons2025https://conductscience.org/library/papers/40972648PubMed
40529698Biological threat preparedness through vaccine development and stockpiling: challenges and strategic implications.Front Public Health2025https://conductscience.org/library/papers/40529698PubMed
40417828rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40417828PubMed
40279638Novel Bivalent mRNA-LNP Vaccine for Highly Effective Protection against Pneumonic Plague.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40279638PubMed
40022523Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical Trials.Med Sci Monit2025https://conductscience.org/library/papers/40022523PubMed
39852845Live Plague Vaccine Development: Past, Present, and Future.Vaccines (Basel)2025https://conductscience.org/library/papers/39852845PubMed
39772023The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice.Vaccines (Basel)2024https://conductscience.org/library/papers/39772023PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39242587

GET https://conductscience.org/api/papers/v1/39242587/references?page=2